Validated using a knockout cell line
Recombinant
RabMAb

Anti-CD168 antibody [EPR4055] (ab108339)

Publishing research using ab108339? Please let us know so that we can cite the reference in this datasheet.

ab108339 has been referenced in 3 publications.

  • Wang K & Zhang T Prognostic significance of CD168 overexpression in colorectal cancer. Oncol Lett 12:2555-2559 (2016). IHC ; Human . PubMed: 27698827
  • Wang D  et al. Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma. Oncotarget 7:39957-39969 (2016). WB, IHC . PubMed: 27220886
  • Picaud L  et al. Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose barrier on ovarian tumor progression. J Ovarian Res 7:40 (2014). WB ; Human . PubMed: 24739440

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up